VictorJThannickalMD

Summary

• Dr. Thannickal is Professor of Medicine and the Harry B. Greenberg Chair, Department of Medicine at Tulane University School of Medicine. Dr. Thannickal’s research is focused on cellular and molecular mechanisms of lung repair and regeneration. This work has advanced fundamental understanding of myofibroblast origins, differentiation, and survival in pulmonary fibrosis. The clinical impact of his work is evidenced by current and emerging anti-fibrotic therapies in pre-clinical/clinical development; this includes inhibitors of FAK/Akt, MRTF-A/ROCK and NADPH oxidase-4 (NOX4). His laboratory was the first to identify an essential role for NOX4 in organ fibrosis and has elucidated mechanisms by which redox imbalance and metabolic alterations contribute to age-dependent susceptibility to fibrosis. Active studies are focused on elucidating mechanisms of cellular senescence, oxidative stress, and aging in the context of chronic lung diseases, in concert with the development of therapeutics and biomarkers for complex lung diseases. His research program is funded by the National Institutes of Health and the U.S. Department of Veterans Affairs.
  
  Dr. Thannickal is an elected member of American Association of Physicians, and received the American Thoracic Society (ATS) Recognition Award for Scientific Accomplishments in 2016. He currently serves on the Editorial Boards of the Journal of Clinical Investigation (Consulting Editor), as well those of the American Journal of Respiratory and Critical Care Medicine and the American Journal of Pathology; he is an Associate Editor of the American Journal of Respiratory Cell and Molecular Biology.